.png){kind=icon}
.png){kind=icon}
Return
Change management considerations for orally inhaled and nasal drug products and other drug device combination products in the European Union
.png){kind=icon}
PRE
AI
M
B
L
DOI：10.1016/j.xphs.2026.104357.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
In this paper, the International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS), discusses the current regulatory landscape associated with change management of orally inhaled and nasal drug products (OINDP) and other drug device combination products in the European Union.
Journal
IF:
3.8
Papers:
1.1W
Citations:
2.6W
Organization
Cited Papers